Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.470
-0.005-0.09%
Volume:43.12M
Turnover:236.09M
Market Cap:102.20B
PE:36.07
High:5.530
Open:5.455
Low:5.420
Close:5.475
52wk High:8.647
52wk Low:4.136
Shares:18.68B
HK Float Shares:18.68B
Volume Ratio:0.59
T/O Rate:0.23%
Dividend:0.12
Dividend Rate:2.20%
EPS(LYR):0.152
ROE:14.07%
ROA:7.51%
PB:2.69
PE(LYR):36.07
PS:2.60

Loading ...

Sino Biopharma Deepens GSK Tie, Wins China Commercialization Rights for Trelegy and Anoro Inhalers

Reuters
·
Jul 08

Sino Biopharmaceutical - Sbp Group Deepens Exclusive Strategic Collaboration with GSK for Respiratory Therapies in China

THOMSON REUTERS
·
Jul 08

Sino Biopharmaceutical - Co Will be Responsible for Importation, Distribution, Others for These Products in Mainland China

THOMSON REUTERS
·
Jul 08

Sino Biopharmaceutical - Sbp Group Obtains China Commercialisation Rights for Gsk's Trelegy Ellipta and Anoro Ellipta

THOMSON REUTERS
·
Jul 08

SBP GROUP Shares Surge Over 4% in Early Trading Following Exclusive Licensing Deal with AstraZeneca for TQC3721

Stock News
·
Jul 08

Stock Track | SBP GROUP Soars 5.39% Intraday on $1.9 Billion AstraZeneca Licensing Deal

Stock Track
·
Jul 08

Movement Alert|Sino Biopharmaceutical Rises 3.73% in Regular Trading, AstraZeneca Licensing Deal Worth Up to $1.9 Billion

Market Focus
·
Jul 08

Sino Biopharmaceutical Enters Exclusive License Agreement with Astrazeneca for Tqc3721

Reuters
·
Jul 08

Sino Biopharma Says Tqc3721 Posts Phase Iib COPD Data, Advances to Phase III in China

Reuters
·
Jul 08

Sino Biopharmaceutical - Eligible for $200 Mln Upfront, Milestones up to $1.9 Bln, and Tiered Royalties

THOMSON REUTERS
·
Jul 08

Sino Biopharmaceutical - Astrazeneca Granted Exclusive Rights to Tqc3721 Outside China

THOMSON REUTERS
·
Jul 08

Movement Alert|Sino Biopharmaceutical Falls 3.17% in Regular Trading, Trading at 4.9 HKD

Market Focus
·
Jul 07

Sino Biopharmaceutical Stock Rallies 6.5% in Hong Kong, Outperforms Competitors

Dow Jones
·
Jul 06

Hong Kong Market Midday Update: Hang Seng Index Gains 0.83%, Tech Index Up 1.16% with Broad Tech Sector Gains; Power Equipment Stocks Strong, PCB Concept Shares Slump; Kuaishou Surges Over 5%

Deep News
·
Jul 06

Biopharma Stocks Continue to Rally in Early Trading Session

Deep News
·
Jul 06

Innovative Drug Sector Maintains Upward Momentum on Favorable Regulatory Developments and Accelerating Internationalization

Stock News
·
Jul 06

Stock Track | SBP GROUP Soars 5.49% Intraday on Drug Pipeline Progress and Favorable Policy Support

Stock Track
·
Jul 06

Movement Alert|Sino Biopharmaceutical Rises 3.38% in Regular Trading, NDA Acceptance and Medical Insurance Policy Boost Sentiment

Market Focus
·
Jul 06

Sino Biopharma Unit's Application for Analgesic Accepted in China

MT Newswires Live
·
Jul 03

Sino Biopharm’s NDA for First-in-Class Long-Acting Ropivacaine Analgesic Accepted by China CDE

Bulletin Express
·
Jul 03